Home › Markets › Health Care › XXII

22nd Century Group Inc. (XXII)

XXII trades on Nasdaq in Health Care, Medicinal Chemicals and Botanical Products . Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · October 14, 2026
$0.6666
-7.98% on the day
Market cap
$476K
Nano cap
Revenue · 2025
$17.6M
Prior year not contiguous
Net income · 2025
-$5.1M
-28.7% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax), period ending 2025-12-31, https://www.sec.gov/Archives/edgar/data/1347858/000110465926034814/0001104659-26-034814-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), period ending 2025-12-31.

Profile

FieldValue
TickerXXII on Nasdaq
SectorHealth Care
Industry Medicinal Chemicals and Botanical Products
CountryUnited States
IPO yearNot reported by the screener
SEC CIK0001347858
SEC industry codeCigarettes
Incorporated inFL

Financials · 2025

LineValue
Revenue$17.6M
Net income-$5.1M
Operating income-$11.6M
Net margin-28.7%
Operating margin-65.8%
Revenue growthNo prior-year revenue to compare
Cash$7.1M
Total assets$27.0M
P/E (computed)Net income was not positive
P/S (computed)0.0×

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B32026-08-14
Latest annual report10-K2026-03-26
Latest quarterly / interim10-Q2026-08-14
Latest current report8-K2026-09-01
Latest proxyDEF 14A2026-06-23

Source: SEC EDGAR submissions feed, 912 recent filings. All filings on EDGAR.

Peers in Medicinal Chemicals and Botanical Products

TickerCompanyPriceDayMarket cap
IMCCIM Cannabis Corp. Common Shares$1.36-6.85%$2.2M
AKANAkanda Corp. Common Shares$1.38-15.85%$3.3M
NAIINatural Alternatives International Inc.$1.15-5.74%$7.2M
BONBon Natural Life Limited$1.12-0.76%$9.1M
MTEXMannatech Incorporated$7.56-2.95%$14.6M
BTMDBiote Corp.$1.04-8.77%$37.4M
ISPRIspire Technology Inc.$1.45-1.36%$83.7M
FTLFFitLife Brands Inc.$9.07-1.73%$85.2M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier